SCHEMBL15547174

SCHEMBL15547174

COc1cc(C#N)c(Cc2ccc(C)c(F)c2F)c(C#N)c1O

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.33
ALDH1A1 P00352 1/20 0.33
HTR2A P28223 3/20 0.33
AR P10275 2/20 0.33
HTR2C P28335 1/20 0.33
NR3C1 P04150 2/20 0.32
PGR P06401 2/20 0.32
NR3C2 P08235 2/20 0.32
PDE10A Q9Y233 1/20 0.32
FFAR1 O14842 1/20 0.32
FFAR4 Q5NUL3 1/20 0.32
EGFR P00533 1/20 0.32
LTC4S Q16873 1/20 0.32
CXCR2 P25025 1/20 0.32
KDM4E B2RXH2 1/20 0.31
LMNA P02545 1/20 0.31
MAPK1 P28482 1/20 0.31
MAOA P21397 1/20 0.31
MAOB P27338 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15535312 0.86 ROCK2 (0.35) TSHRALDH1A1HTR2AARNR3C1
SCHEMBL15535528 0.85 ESR1 (0.35) ALDH1A1FFAR1FFAR4LMNA
SCHEMBL15534796 0.83 GAA (0.40) TSHRALDH1A1HTR2AARHTR2C
SCHEMBL16969086 0.83 AR (0.40) TSHRALDH1A1HTR2AARHTR2C
SCHEMBL16969063 0.82 NR3C1 (0.38) TSHRALDH1A1HTR2AARHTR2C
SCHEMBL29392134 0.82 NR3C1 (0.38) TSHRALDH1A1HTR2AARHTR2C
SCHEMBL15535388 0.82 ALDH1A1 (0.42) TSHRALDH1A1HTR2AARHTR2C
SCHEMBL15536097 0.81 HTR2A (0.48) TSHRALDH1A1HTR2AARHTR2C
SCHEMBL22635724 0.80 GAA (0.37) TSHRALDH1A1HTR2AARHTR2C
SCHEMBL15535741 0.79 ALDH1A1 (0.46) TSHRALDH1A1HTR2AARHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220047540-A1 CATECHOL O-METHYLTRANSFERASE ACTIVITY INHIBITING COMPOUNDS ORION CORP (FI) 2022-02-17 US disclosed
US-20200352898-A1 CATECHOL O-METHYLTRANSFERASE ACTIVITY INHIBITING COMPOUNDS ORION CORP (FI) 2020-11-12 US disclosed
US-20190029990-A1 CATECHOL O-METHYLTRANSFERASE ACTIVITY INHIBITING COMPOUNDS ORION CORP (FI) 2019-01-31 US disclosed
US-20170165219-A1 CATECHOL O-METHYLTRANSFERASE ACTIVITY INHIBITING COMPOUNDS ORION CORP (FI) 2017-06-15 US disclosed
EP-2855426-B1 CATECHOL O-METHYLTRANSFERASE ACTIVITY INHIBITING COMPOUNDS ORION CORP (FI) 2017-01-04 EP disclosed
US-9458128-B2 Catechol O-methyltransferase activity inhibiting compounds ORION CORPORATION (FI) 2016-10-04 US disclosed
US-20150218124-A1 CATECHOL O-METHYLTRANSFERASE ACTIVITY INHIBITING COMPOUNDS ORION CORPORATION (FI) 2015-08-06 US disclosed
EP-2855426-A1 CATECHOL O-METHYLTRANSFERASE ACTIVITY INHIBITING COMPOUNDS Orion Corporation (FI) 2015-04-08 EP disclosed
WO-2013175053-A1 CATECHOL O-METHYLTRANSFERASE ACTIVITY INHIBITING COMPOUNDS ORION CORPORATION (FI) 2013-11-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170165219-A1 CATECHOL O-METHYLTRANSFERASE ACTIVITY INHIBITING COMPOUNDS COMT, PNMT, HNMT TSHR 2534/4885ALDH1A1 42/4885HTR2A 591/4885
US-20200352898-A1 CATECHOL O-METHYLTRANSFERASE ACTIVITY INHIBITING COMPOUNDS COMT, PNMT, HNMT TSHR 2534/4885ALDH1A1 42/4885HTR2A 591/4885
US-20190029990-A1 CATECHOL O-METHYLTRANSFERASE ACTIVITY INHIBITING COMPOUNDS COMT, PNMT, HNMT TSHR 2534/4885ALDH1A1 42/4885HTR2A 591/4885
US-20150218124-A1 CATECHOL O-METHYLTRANSFERASE ACTIVITY INHIBITING COMPOUNDS COMT, PNMT, HNMT TSHR 2534/4885ALDH1A1 42/4885HTR2A 591/4885
US-20220047540-A1 CATECHOL O-METHYLTRANSFERASE ACTIVITY INHIBITING COMPOUNDS COMT, PNMT, HNMT TSHR 2534/4885ALDH1A1 42/4885HTR2A 591/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.